BRIGHI, NICOLE
BRIGHI, NICOLE
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Dottorandi
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study
2024 Casadei C.; Scarpi E.; Conteduca V.; Gurioli G.; Cursano M.C.; Brighi N.; Lolli C.; Schepisi G.; Basso U.; Fornarini G.; Bleve S.; Farolfi A.; Altavilla A.; Burgio S.L.; Giunta E.F.; Gianni C.; Filograna A.; Ulivi P.; Olmos D.; Castro E.; De Giorgi U.
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer
2023 Cursano, Maria Concetta; Giunta, Emilio Francesco; Scarpi, Emanuela; Casadei, Chiara; Virga, Alessandra; Ulivi, Paola; Bleve, Sara; Brighi, Nicole; Ravaglia, Giorgia; Pantano, Francesco; Conteduca, Vincenza; Santini, Daniele; De Giorgi, Ugo
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors
2023 Nicole Brighi; Giuseppe Lamberti; Elisa Andrini; Cristina Mosconi; Lisa Manuzzi; Giada Donati; Andrea Lisotti; Davide Campana
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide
2022 Conteduca V.; Casadei C.; Scarpi E.; Brighi N.; Schepisi G.; Lolli C.; Gurioli G.; Toma I.; Poti G.; Farolfi A.; De Giorgi U.
Diagnostic performance of endoscopic ultrasound-guided tissue acquisition of splenic lesions: systematic review with pooled analysis
2022 Lisotti A.; Crino S.F.; Mangiavillano B.; Cominardi A.; Ofosu A.; Brighi N.; Metelli F.; Zagari R.M.; Facciorusso A.; Fusaroli P.
Response
2022 Lisotti A.; Facciorusso A.; Brighi N.; Fusaroli P.
An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA
2021 Conteduca V.; Brighi N.; Conteduca D.; Bleve S.; Gianni C.; Schepisi G.; Iaia M.L.; Gurioli G.; Lolli C.; De Giorgi U.
Circulating Androgen Receptor for Prognosis and Treatment Selection in Prostate Cancer
2021 Conteduca V.; Wetterskog D.; Gonzalez-Billalabeitia E.; Brighi N.; De Giorgi U.; Attard G.
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome
2021 Conteduca V.; Scarpi E.; Caroli P.; Lolli C.; Gurioli G.; Brighi N.; Poti G.; Farolfi A.; Altavilla A.; Schepisi G.; Matteucci F.; Paganelli G.; De Giorgi U.
Conservative management of malignant gastric outlet obstruction syndrome-evidence based evaluation of endoscopic ultrasound-guided gastroentero-anastomosis
2021 Cominardi A.; Tamanini G.; Brighi N.; Fusaroli P.; Lisotti A.
Contrast-enhanced EUS for the characterization of mural nodules within pancreatic cystic neoplasms: systematic review and meta-analysis
2021 Lisotti A.; Napoleon B.; Facciorusso A.; Cominardi A.; Crino S.F.; Brighi N.; Gincul R.; Kitano M.; Yamashita Y.; Marchegiani G.; Fusaroli P.
Endoscopic ultrasound assessment and tissue acquisition of mediastinal and abdominal lymph nodes
2021 Tamanini G.; Cominardi A.; Brighi N.; Fusaroli P.; Lisotti A.
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging
2021 Conteduca V.; Poti G.; Caroli P.; Russi S.; Brighi N.; Lolli C.; Schepisi G.; Romeo A.; Matteucci F.; Paganelli G.; Marchetti P.; De Giorgi U.
Immunotherapy and its development for gynecological (Ovarian, endometrial and cervical) tumors: From immune checkpoint inhibitors to chimeric antigen receptor (car)-T cell therapy
2021 Schepisi G.; Casadei C.; Toma I.; Poti G.; Iaia M.L.; Farolfi A.; Conteduca V.; Lolli C.; Ravaglia G.; Brighi N.; Altavilla A.; Martinelli G.; De Giorgi U.
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma
2021 Conteduca V.; Scarpi E.; Farolfi A.; Brighi N.; Rossi L.; Gurioli G.; Lolli C.; Schepisi G.; Bleve S.; Gianni C.; Virga A.; Altavilla A.; Burgio S.L.; Menna C.; De Giorgi U.
New prognostic biomarkers in metastatic castration-resistant prostate cancer
2021 Conteduca V.; Mosca A.; Brighi N.; de Giorgi U.; Rescigno P.
Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study
2021 Conteduca V.; Wetterskog D.; Castro E.; Scarpi E.; Romero-Laorden N.; Gurioli G.; Jayaram A.; Lolli C.; Schepisi G.; Wingate A.; Casadei C.; Lozano R.; Brighi N.; Aragon I.M.; Marin-Aguilera M.; Gonzalez-Billalabeitia E.; Mellado B.; Olmos D.; Attard G.; De Giorgi U.
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients
2021 Conteduca V.; Scarpi E.; Wetterskog D.; Brighi N.; Ferroni F.; Rossi A.; Romanel A.; Gurioli G.; Bleve S.; Gianni C.; Schepisi G.; Lolli C.; Cortesi P.; Matteucci F.; Barone D.; Paganelli G.; Demichelis F.; Beltran H.; Attard G.; De Giorgi U.
The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives
2021 Brighi N.; Conteduca V.; Lolli C.; Gurioli G.; Schepisi G.; Palleschi M.; Mariotti M.; Casadei C.; De Giorgi U.
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study
2020 Brighi N.; Panzuto F.; Modica R.; Gelsomino F.; Albertelli M.; Pusceddu S.; Massironi S.; Lamberti G.; Rinzivillo M.; Faggiano A.; Spallanzani A.; Ferone D.; Prinzi N.; Rossi R.E.; Annibale B.; Colao A.M.; Campana D.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study | Casadei C.; Scarpi E.; Conteduca V.; Gurioli G.; Cursano M.C.; Brighi N.; Lolli C.; Schepisi G.; ...Basso U.; Fornarini G.; Bleve S.; Farolfi A.; Altavilla A.; Burgio S.L.; Giunta E.F.; Gianni C.; Filograna A.; Ulivi P.; Olmos D.; Castro E.; De Giorgi U. | 2024-01-01 | EUROPEAN UROLOGY OPEN SCIENCE | - | 1.01 Articolo in rivista | Inherited Mutations in DNA Damage Repair Genes from Meet-URO 10 Study.pdf |
| Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer | Cursano, Maria Concetta; Giunta, Emilio Francesco; Scarpi, Emanuela; Casadei, Chiara; Virga, Ales...sandra; Ulivi, Paola; Bleve, Sara; Brighi, Nicole; Ravaglia, Giorgia; Pantano, Francesco; Conteduca, Vincenza; Santini, Daniele; De Giorgi, Ugo | 2023-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | Cursano et al, Impact of somatic_ 2023_august.pdf |
| Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors | Nicole Brighi; Giuseppe Lamberti; Elisa Andrini; Cristina Mosconi; Lisa Manuzzi; Giada Donati; An...drea Lisotti; Davide Campana | 2023-01-01 | CURRENT ONCOLOGY | - | 1.01 Articolo in rivista | curroncol-30-00106-v2.pdf |
| Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide | Conteduca V.; Casadei C.; Scarpi E.; Brighi N.; Schepisi G.; Lolli C.; Gurioli G.; Toma I.; Poti ...G.; Farolfi A.; De Giorgi U. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | aseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer.pdf |
| Diagnostic performance of endoscopic ultrasound-guided tissue acquisition of splenic lesions: systematic review with pooled analysis | Lisotti A.; Crino S.F.; Mangiavillano B.; Cominardi A.; Ofosu A.; Brighi N.; Metelli F.; Zagari R....M.; Facciorusso A.; Fusaroli P. | 2022-01-01 | GASTROENTEROLOGY REPORT | - | 1.01 Articolo in rivista | Gastroenterol Rep 2022 Lisotti.pdf; goac022_supplementary_data.zip |
| Response | Lisotti A.; Facciorusso A.; Brighi N.; Fusaroli P. | 2022-01-01 | GASTROINTESTINAL ENDOSCOPY | - | 1.04 Replica / breve intervento (e simili) | - |
| An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA | Conteduca V.; Brighi N.; Conteduca D.; Bleve S.; Gianni C.; Schepisi G.; Iaia M.L.; Gurioli G.; L...olli C.; De Giorgi U. | 2021-01-01 | EXPERT REVIEW OF MOLECULAR DIAGNOSTICS | - | 1.01 Articolo in rivista | - |
| Circulating Androgen Receptor for Prognosis and Treatment Selection in Prostate Cancer | Conteduca V.; Wetterskog D.; Gonzalez-Billalabeitia E.; Brighi N.; De Giorgi U.; Attard G. | 2021-01-01 | EUROPEAN UROLOGY ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome | Conteduca V.; Scarpi E.; Caroli P.; Lolli C.; Gurioli G.; Brighi N.; Poti G.; Farolfi A.; Altavil...la A.; Schepisi G.; Matteucci F.; Paganelli G.; De Giorgi U. | 2021-01-01 | MOLECULAR ONCOLOGY | - | 1.01 Articolo in rivista | Molecular Oncology - 2021 - Conteduca - Combining liquid biopsy and functional imaging analysis in metastatic.pdf; Supplementary materials.zip |
| Conservative management of malignant gastric outlet obstruction syndrome-evidence based evaluation of endoscopic ultrasound-guided gastroentero-anastomosis | Cominardi A.; Tamanini G.; Brighi N.; Fusaroli P.; Lisotti A. | 2021-01-01 | WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY | - | 1.01 Articolo in rivista | WJGO 2021.pdf |
| Contrast-enhanced EUS for the characterization of mural nodules within pancreatic cystic neoplasms: systematic review and meta-analysis | Lisotti A.; Napoleon B.; Facciorusso A.; Cominardi A.; Crino S.F.; Brighi N.; Gincul R.; Kitano M....; Yamashita Y.; Marchegiani G.; Fusaroli P. | 2021-01-01 | GASTROINTESTINAL ENDOSCOPY | - | 1.01 Articolo in rivista | - |
| Endoscopic ultrasound assessment and tissue acquisition of mediastinal and abdominal lymph nodes | Tamanini G.; Cominardi A.; Brighi N.; Fusaroli P.; Lisotti A. | 2021-01-01 | WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY | - | 1.01 Articolo in rivista | WJGO 2021 bis.pdf |
| Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging | Conteduca V.; Poti G.; Caroli P.; Russi S.; Brighi N.; Lolli C.; Schepisi G.; Romeo A.; Matteucci... F.; Paganelli G.; Marchetti P.; De Giorgi U. | 2021-01-01 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | - | 1.01 Articolo in rivista | 1758835920987654.pdf |
| Immunotherapy and its development for gynecological (Ovarian, endometrial and cervical) tumors: From immune checkpoint inhibitors to chimeric antigen receptor (car)-T cell therapy | Schepisi G.; Casadei C.; Toma I.; Poti G.; Iaia M.L.; Farolfi A.; Conteduca V.; Lolli C.; Ravagli...a G.; Brighi N.; Altavilla A.; Martinelli G.; De Giorgi U. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-13-00840-v2.pdf |
| Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma | Conteduca V.; Scarpi E.; Farolfi A.; Brighi N.; Rossi L.; Gurioli G.; Lolli C.; Schepisi G.; Blev...e S.; Gianni C.; Virga A.; Altavilla A.; Burgio S.L.; Menna C.; De Giorgi U. | 2021-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | fonc-11-716467.pdf; Table 1.DOCX |
| New prognostic biomarkers in metastatic castration-resistant prostate cancer | Conteduca V.; Mosca A.; Brighi N.; de Giorgi U.; Rescigno P. | 2021-01-01 | CELLS | - | 1.01 Articolo in rivista | - |
| Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study | Conteduca V.; Wetterskog D.; Castro E.; Scarpi E.; Romero-Laorden N.; Gurioli G.; Jayaram A.; Lol...li C.; Schepisi G.; Wingate A.; Casadei C.; Lozano R.; Brighi N.; Aragon I.M.; Marin-Aguilera M.; Gonzalez-Billalabeitia E.; Mellado B.; Olmos D.; Attard G.; De Giorgi U. | 2021-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients | Conteduca V.; Scarpi E.; Wetterskog D.; Brighi N.; Ferroni F.; Rossi A.; Romanel A.; Gurioli G.; ...Bleve S.; Gianni C.; Schepisi G.; Lolli C.; Cortesi P.; Matteucci F.; Barone D.; Paganelli G.; Demichelis F.; Beltran H.; Attard G.; De Giorgi U. | 2021-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives | Brighi N.; Conteduca V.; Lolli C.; Gurioli G.; Schepisi G.; Palleschi M.; Mariotti M.; Casadei C....; De Giorgi U. | 2021-01-01 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study | Brighi N.; Panzuto F.; Modica R.; Gelsomino F.; Albertelli M.; Pusceddu S.; Massironi S.; Lambert...i G.; Rinzivillo M.; Faggiano A.; Spallanzani A.; Ferone D.; Prinzi N.; Rossi R.E.; Annibale B.; Colao A.M.; Campana D. | 2020-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | - |